TIRR inhibits the 53BP1-p53 complex to alter cell-fate programs
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Molecular Cell
- Vol. 81 (12) , 2583-2595.e6
Abstract
No abstract availableKeywords
Funding Information
- NIH
This publication has 50 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Playing the End Game: DNA Double-Strand Break Repair Pathway ChoiceMolecular Cell, 2012
- Molecular Basis for the Association of Human E4B U Box Ubiquitin Ligase with E2-Conjugating Enzymes UbcH5c and Ubc4Structure, 2010
- Structural Insight into p53 Recognition by the 53BP1 Tandem Tudor DomainJournal of Molecular Biology, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Preparation of Recombinant Peptides with Site- and Degree-Specific Lysine 13C-MethylationBiochemistry, 2009
- Role for 53BP1 Tudor Domain Recognition of p53 Dimethylated at Lysine 382 in DNA Damage SignalingJournal of Biological Chemistry, 2008
- Modulation of p53 Function by SET8-Mediated Methylation at Lysine 382Molecular Cell, 2007
- Structural Basis for the Methylation State-Specific Recognition of Histone H4-K20 by 53BP1 and Crb2 in DNA RepairCell, 2006
- Comparison of BRCT domains of BRCA1 and 53BP1: A biophysical analysisProtein Science, 2004